TRILLIUM THERAPEUTICS INC. Shareholders' Equity
TRILLIUM THERAPEUTICS INC. had Shareholders' Equity of $243.16 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2021-11-12
- 2021-09-30: Stockholders' Equity Attributable to Parent $243.16M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $259.57M.
- 2021-03-31: Stockholders' Equity Attributable to Parent $272.99M.
- 2020-12-31: Stockholders' Equity Attributable to Parent $278.85M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2021-09-30 | $243.16M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $259.57M 10-Q · filed 2021-11-12 |
| 2021-03-31 | $272.99M 10-Q · filed 2021-11-12 |
| 2020-12-31 | $278.85M 10-Q · filed 2021-11-12 |
| 2020-09-30 | $272.81M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $119.42M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $115.64M 10-Q · filed 2021-11-12 |
| 2019-12-31 | -$1.33M 10-Q · filed 2021-11-12 |
| 2018-12-31 | $27.58M 10-K · filed 2021-03-18 |